Kleffel et al. [32] also demonstrated a positive influence of PD-1 on the phosphorylation of ribosomal protein S6 (RPS6), a downstream signaling target of mTOR and marker of its activity, which is associated with poor prognosis in renal cancer [40] and many other cancers [41,42]. The gene discussed is PDCD1; the disease is cancer.